Table 1. Lipid phenotypes of the study collective (n = 21).
Apo E type | Cholesterola | Triglyceridesa | LDL chola | HDL chola | |
HLP Type III patients | 2/2 | 524 | 443 | NA | 32 |
2/2 | 764 | 774 | NA | 89 | |
2/2 | 571 | 666 | NA | 33 | |
2/2 | 556 | 498 | NA | 82 | |
2/2 | 350 | 816 | NA | 42 | |
2/2 | 263 | 322 | NA | 43 | |
2/2 | 404 | 753 | NA | 34 | |
2/2 | 302 | 620 | NA | 74 | |
2/2 | 132 | 69 | NA | 24 | |
Mean (±SD) | 430 (±192) | 551 (±244) | 50 (±24) | ||
Familial defective Apo B-100 HLP patients | 3500 heb | 309 | 78 | 222 | 71 |
3500 he | 288 | 145 | 216 | 43 | |
3500 he | 315 | 241 | 209 | 58 | |
3500 he | 316 | 52 | 261 | 45 | |
3500 he | 292 | 136 | 168 | 47 | |
3500 he | 278 | 56 | 202 | 65 | |
3500 he | 369 | 102 | 287 | 52 | |
3500 he | 171 | 161 | 96 | 43 | |
3500 he | 347 | 102 | 282 | 45 | |
3500 he | 259 | 104 | 192 | 46 | |
Mean (±SD) | 294 (±51) | 118 (±56) | 214 (±57) | 51 (±10) | |
Add. pat. | 3/3 | 164 | 152 | 79 | 55 |
3/4 | 294 | 232 | 214 | 34 |
HDL, high-density lipoprotein; HPL, hyperlipoproteinaemia; LDL, low-density lipoprotein.
aCholesterol and triglycerides in mg dl–1.
bApo B 3500 heterozygotes.